Amrize (NYSE:AMRZ) Rating Lowered to Neutral at JPMorgan Chase & Co.

Key Points

• JPMorgan downgraded Amrize from “overweight” to “neutral” while setting a $52 price target, implying 21.52% upside from the prior close.
• Analyst sentiment is mixed, with MarketBeat reporting a consensus “Hold” rating and an average price target of $56.38. Amrize recently missed quarterly EPS estimates, reporting $0.88 versus the $0.92 consensus.
• Amrize shares opened at $42.79, near their 52-week low of $42.72, while insiders purchased nearly 19,000 shares worth approximately $884,535 over the past three months.

Amrize (NYSE:AMRZ - Get Free Report) was downgraded by investment analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating in a research note issued to investors on Wednesday, Briefing.com reports. They presently have a $52.00 target price on the stock. JPMorgan Chase & Co.'s target price suggests a potential upside of 21.52% from the stock's previous close.

Other research analysts have also issued research reports about the stock. Oppenheimer decreased their target price on shares of Amrize from $68.00 to $65.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 21st. Royal Bank Of Canada cut Amrize from a "sector perform" rating to an "underperform" rating and cut their price target for the company from $60.00 to $48.00 in a research note on Monday, August 10th. Wells Fargo & Company lowered their price objective on Amrize from $65.00 to $58.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 8th. William Blair set a $40.00 price objective on Amrize in a report on Wednesday. Finally, Sanford C. Bernstein reiterated an "outperform" rating on shares of Amrize in a research report on Monday, June 22nd. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $56.38.

Amrize Stock Down 2.1%

AMRZ stock opened at $42.79 on Wednesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.10 and a quick ratio of 0.73. The stock has a market capitalization of $23.67 billion, a price-to-earnings ratio of 19.72, a PEG ratio of 0.97 and a beta of 0.12. The business's fifty day moving average price is $49.11 and its two-hundred day moving average price is $53.52. Amrize has a fifty-two week low of $42.72 and a fifty-two week high of $65.94.

Amrize (NYSE:AMRZ - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.22%. The business had revenue of $3.49 billion during the quarter. On average, equities analysts anticipate that Amrize will post 2.74 earnings per share for the current year.

Insider Activity at Amrize

In other Amrize news, insider Stephen S. Clark bought 5,260 shares of the firm's stock in a transaction on Tuesday, August 11th. The shares were purchased at an average price of $47.31 per share, for a total transaction of $248,850.60. Following the completion of the transaction, the insider directly owned 10,637 shares in the company, valued at approximately $503,236.47. The trade was a 97.82% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Jacques Wolf Sanche bought 4,150 shares of the stock in a transaction on Wednesday, August 26th. The shares were acquired at an average cost of $45.02 per share, with a total value of $186,833.00. Following the purchase, the director owned 9,766 shares of the company's stock, valued at approximately $439,665.32. This represents a 73.90% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have acquired 18,983 shares of company stock worth $884,535 in the last three months. Insiders own 0.54% of the company's stock.

Institutional Investors Weigh In On Amrize

Several hedge funds and other institutional investors have recently made changes to their positions in AMRZ. California State Teachers Retirement System boosted its position in Amrize by 5,444.5% in the second quarter. California State Teachers Retirement System now owns 30,472,836 shares of the company's stock valued at $1,624,202,000 after buying an additional 29,923,230 shares in the last quarter. Norges Bank bought a new stake in shares of Amrize during the fourth quarter worth $929,333,000. Harris Associates L P acquired a new position in shares of Amrize during the fourth quarter worth $615,406,000. Wellington Management Group LLP increased its holdings in shares of Amrize by 48.8% during the third quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company's stock worth $561,018,000 after buying an additional 3,809,133 shares in the last quarter. Finally, Marshall Wace LLP lifted its stake in shares of Amrize by 865.4% in the 3rd quarter. Marshall Wace LLP now owns 2,889,660 shares of the company's stock valued at $139,436,000 after acquiring an additional 2,590,336 shares during the last quarter.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source